ARCHIVES

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

December 12, 2003

Survival For ALL Increased To 94 Percent In Recent Years

December 31, 2010

Scientists Brief Writers On Progress In Cancer Research

April 18, 1975

Recalcitrant Cancer Bill Heading To Senate May Face Hold in the Lame Duck Session

November 16, 2012

IOM Report Lists Cancer CER Priorities

July 3, 2009

Anti-Impoundment, Panel Stay In Cancer Renewal Act; Conferees Finally Agree On Research Training Bill

June 14, 1974